Related Experiment Video
Updated: Mar 30, 2026

08:14
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
13.2K
[A quick and efficient method to generate hemophilia B mouse models by the CRISPR/Cas system]
Qi-han Wang1, Cong Huai1, Rui-lin Sun2
1State Key Laboratory of Genetic Engineering, School of Life Science, Fudan University, Shanghai 200433, China.
Yi Chuan = Hereditas
|November 20, 2015
Summary
Researchers efficiently created hemophilia B mouse models using CRISPR/Cas gene editing. These knockout mice exhibit significantly reduced coagulation factor IX activity, confirming their utility for studying this X-linked bleeding disorder.
Area of Science:
- Genetics and Genomics
- Molecular Biology
- Hematology
Related Concept Videos
CRISPR
59.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
59.1K
CRISPR/Cas9 Genome Editing
2.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.6K

